Viewing StudyNCT00192413



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192413
Status: COMPLETED
Last Update Posted: 2012-03-14
First Post: 2005-09-13

Brief Title: Trial to Compare the Safety Tolerability and Efficacy of Influenza Virus Vaccine CAIV-T With Inactivated Influenza Vaccine Trivalent Types A B in Adults Aged 60 Years and Older Against Culture-confirmed Influenza
Sponsor:
Organization: MedImmune LLC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 3009
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: